Seta Clinic Tokyo, located in Kanda-Surugadai, Chiyoda-ku, Tokyo, was established in 1999 as Japan's first specialized medical institution for immune cell therapy, with pioneering achievements in cancer treatment. Over 26 years since its founding, the clinic has accumulated more than 24,000 treatment cases, and the knowledge and techniques it has gathered represent some of the highest standards in Japan. At the core of the clinic's treatment is "immune cell therapy," a method that cultivates and processes patients' own immune cells to attack cancer. Characterized by extremely minimal side effects, it can be combined with standard treatments such as surgery and chemotherapy, allowing for flexible treatment plans tailored to each patient's condition. Cancer specialists well-versed in immunology, including Director Shigenori Goto and General Director Takashi Kamigaki, provide medical care, and the clinic maintains high expertise in both research and clinical practice through a collaborative chair with Juntendo University Graduate School. Consultation hours are set for mornings and afternoons on weekdays, and the acceptance of various payment methods including credit cards and electronic payments is another convenient feature.